Industry

Biotechnology

Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.

Total Companies
1 341
Biotechnology Industry
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Abbvie Inc
NYSE:ABBV
Loading...
9% Overvalued
72 / 100
43 / 100
$403.8B
Amgen Inc
NASDAQ:AMGN
Loading...
10% Overvalued
64 / 100
28 / 100
$176.1B
Gilead Sciences Inc
NASDAQ:GILD
Loading...
2% Overvalued
68 / 100
63 / 100
$152.4B
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Loading...
26% Overvalued
60 / 100
87 / 100
$115.2B
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Loading...
4% Overvalued
56 / 100
97 / 100
$81.3B
CSL Ltd
ASX:CSL
Loading...
22% Undervalued
55 / 100
63 / 100
$55.6B
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Loading...
26% Overvalued
50 / 100
48 / 100
$52.4B
argenx SE
XBRU:ARGX
Loading...
23% Overvalued
57 / 100
99 / 100
$51.8B
Insmed Inc
NASDAQ:INSM
Loading...
60% Overvalued
31 / 100
61 / 100
$37B
Beigene Ltd
SSE:688235
Loading...
19% Overvalued
38 / 100
75 / 100
$34.3B
Beigene Ltd
HKEX:6160
Loading...
15% Overvalued
38 / 100
75 / 100
$33B
Natera Inc
NASDAQ:NTRA
Loading...
59% Overvalued
29 / 100
71 / 100
$31.5B
Celltrion Inc
KRX:068270
Loading...
23% Overvalued
49 / 100
69 / 100
$27.4B
Biogen Inc
NASDAQ:BIIB
Loading...
10% Undervalued
54 / 100
64 / 100
$25.8B
BioNTech SE
NASDAQ:BNTX
Loading...
42% Overvalued
39 / 100
75 / 100
$22.9B
United Therapeutics Corp
NASDAQ:UTHR
Loading...
21% Overvalued
69 / 100
93 / 100
$20.9B
Genmab A/S
CSE:GMAB
Loading...
78% Overvalued
70 / 100
99 / 100
$19.5B
Incyte Corp
NASDAQ:INCY
Loading...
2% Undervalued
60 / 100
85 / 100
$19.4B
Exact Sciences Corp
NASDAQ:EXAS
Loading...
54% Overvalued
31 / 100
38 / 100
$19.2B
Alteogen Inc
KOSDAQ:196170
Loading...
50% Overvalued
65 / 100
90 / 100
$16.7B
Load More